Evidence map›Paper›PMID 39227390›Full record

ArticleNature communications2024

A molecular mechanism to diversify Ca

Julian Brands, Sergi Bravo, Lars Jürgenliemke, Lukas Grätz, Hannes Schihada, Fabian Frechen, Judith Alenfelder, Cy Pfeil, Paul Georg Ohse, Suzune Hiratsuka and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. PLCβs are recruited to the plasma membrane in macrophages by both Gβγ and GαProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Development of Mutant MBiochemistry · 2025
    Article
  16. An integrated mechanism of GProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. MnInternational journal of molecular sciences · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Julian Brands *Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Sergi Bravo *Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.ORCID 0000-0001-5541-2860
Lars Jürgenliemke *Molecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.ORCID 0009-0001-2701-9276
Lukas GrätzDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6755-0742
Hannes SchihadaDepartment of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany.
Fabian FrechenInstitute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0009-0003-1279-2842
Judith AlenfelderMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.ORCID 0009-0009-3733-3443
Cy PfeilMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Paul Georg OhseMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Suzune HiratsukaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan.
Kouki KawakamiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan.ORCID 0000-0002-2507-8619
Luna C SchmackeDepartment of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany.
Nina HeyckeMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Asuka InoueGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan.ORCID 0000-0003-0805-4049
Gabriele KönigInstitute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Alexander PfeiferInstitute of Pharmacology and Toxicology, University Hospital, University of Bonn, Bonn, Germany.ORCID 0000-0001-8805-6831
Dagmar WachtenInstitute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.ORCID 0000-0003-4800-6332
Gunnar SchulteDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-2700-7013
Torsten SteinmetzerDepartment of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany.
Val J WattsDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute of Drug Discovery, Purdue University, West Lafayette, IN, USA.
Jesús GomezaMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.ORCID 0000-0002-2452-8016
Katharina SimonMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Evi KostenisMolecular, Cellular and Pharmacobiology Section, Institute for Pharmaceutical Biology, University of Bonn, Bonn, Germany. kostenis@uni-bonn.de.ORCID 0000-0001-8284-5514

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 214362475/GRK1873/2Deutsche Forschungsgemeinschaft (German Research Foundation) 290847012/FOR2372Deutsche Forschungsgemeinschaft (German Research Foundation) 494832089 /GRK2873Japan Agency for Medical Research and Development (AMED) JP22ama121038Japan Agency for Medical Research and Development (AMED) JP22zf0127007MEXT | Japan Science and Technology Agency (JST) 22714181MEXT | Japan Science and Technology Agency (JST) JPMJFR215TMEXT | Japan Science and Technology Agency (JST) JPMJMS2023MEXT | Japan Society for the Promotion of Science (JSPS) JP21H04791MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05037MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05113MEXT | Japan Society for the Promotion of Science (JSPS) JPJSBP120213501
6 · The paper itself

Abstract

A long-held tenet in inositol-lipid signaling is that cleavage of membrane phosphoinositides by phospholipase Cβ (PLCβ) isozymes to increase cytosolic Ca

Indexed as

CalciumCalcium SignalingPhospholipase C betaReceptors, G-Protein-CoupledAdenylyl CyclasesAnimalsCRISPR-Cas SystemsCyclic AMPCytosolGene EditingGTP-Binding Protein alpha Subunits, Gq-G11GTP-Binding Protein alpha Subunits, GsGTP-Binding Protein beta SubunitsHEK293 CellsHumansAdenylyl CyclasesCalciumCyclic AMPGTP-Binding Protein alpha Subunits, Gq-G11GTP-Binding Protein alpha Subunits, GsGTP-Binding Protein beta SubunitsPhospholipase C betaReceptors, G-Protein-Coupled

Identifiers

PMID39227390
PMCPMC11372221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.